5 months Cytokinetics Reverses Higher On ‘Pristine’ Results For Bristol Myers-Rivaling Heart Drug Investor's Business Daily
Cytokinetics said Monday its drug “significantly” improved exercise capacity in HCM patients. On Tuesday, Cytokinetics stock reversed higher.
The post Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug ap…